Nephros (NEPH) Cash from Operations (QoQ) (2010 - 2026)
Powered by 
Analysis
Nephros (NEPH) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 140.75% |
| Mar 31, 2026 | -1,003.24% |
| Dec 31, 2025 | 86.87% |
| Sep 30, 2025 | -90.04% |
| Jun 30, 2025 | 208.70% |
| Mar 31, 2025 | -75.31% |
| Dec 31, 2024 | 309.31% |
| Sep 30, 2024 | -24.35% |
| Jun 30, 2024 | 25.45% |
| Mar 31, 2024 | -146.15% |
| Dec 31, 2023 | -145.65% |
| Sep 30, 2023 | 164.60% |
| Jun 30, 2023 | -18.12% |
| Mar 31, 2023 | 241.54% |
| Dec 31, 2022 | -14.71% |
| Sep 30, 2022 | 84.14% |
| Jun 30, 2022 | 40.35% |
| Mar 31, 2022 | -436.42% |
| Dec 31, 2021 | 63.19% |
| Sep 30, 2021 | -677.78% |